CN1785325A - Ready prepared Chinese medicine for treating acute, chronic prostatitis and its preparation method - Google Patents
Ready prepared Chinese medicine for treating acute, chronic prostatitis and its preparation method Download PDFInfo
- Publication number
- CN1785325A CN1785325A CN 200510096360 CN200510096360A CN1785325A CN 1785325 A CN1785325 A CN 1785325A CN 200510096360 CN200510096360 CN 200510096360 CN 200510096360 A CN200510096360 A CN 200510096360A CN 1785325 A CN1785325 A CN 1785325A
- Authority
- CN
- China
- Prior art keywords
- parts
- thick paste
- fine powder
- add
- chinese patent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 30
- 230000001154 acute effect Effects 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title claims description 16
- 201000007094 prostatitis Diseases 0.000 title abstract description 19
- 208000013507 chronic prostatitis Diseases 0.000 title abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 60
- 239000000843 powder Substances 0.000 claims description 55
- 241001057584 Myrrha Species 0.000 claims description 40
- 241000628997 Flos Species 0.000 claims description 28
- 210000000582 semen Anatomy 0.000 claims description 28
- 241000717739 Boswellia sacra Species 0.000 claims description 25
- 239000000706 filtrate Substances 0.000 claims description 24
- 235000012222 talc Nutrition 0.000 claims description 20
- 239000004863 Frankincense Substances 0.000 claims description 16
- 239000002994 raw material Substances 0.000 claims description 14
- 229910052623 talc Inorganic materials 0.000 claims description 14
- 239000000454 talc Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000000284 extract Substances 0.000 claims description 13
- 241000025505 Pyrrosia Species 0.000 claims description 12
- 239000002775 capsule Substances 0.000 claims description 12
- 230000006837 decompression Effects 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 12
- 238000002481 ethanol extraction Methods 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 12
- -1 filtered Substances 0.000 claims description 12
- 239000008187 granular material Substances 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 238000004064 recycling Methods 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 10
- 230000001684 chronic effect Effects 0.000 claims description 8
- 235000003717 Boswellia sacra Nutrition 0.000 claims description 7
- 235000012035 Boswellia serrata Nutrition 0.000 claims description 7
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 15
- 230000001737 promoting effect Effects 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 5
- 230000000202 analgesic effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 210000002307 prostate Anatomy 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- JFPVXVDWJQMJEE-QMTHXVAHSA-N Cefuroxime Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)C(=NOC)C1=CC=CO1 JFPVXVDWJQMJEE-QMTHXVAHSA-N 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 206010039954 Seminal vesiculitis Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010046442 Urethral dilatation Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- CKMXBZGNNVIXHC-UHFFFAOYSA-L ammonium magnesium phosphate hexahydrate Chemical compound [NH4+].O.O.O.O.O.O.[Mg+2].[O-]P([O-])([O-])=O CKMXBZGNNVIXHC-UHFFFAOYSA-L 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 229910052567 struvite Inorganic materials 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 201000010653 vesiculitis Diseases 0.000 description 1
- 229940046284 zinacef Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese patent medicine for treating acute or chronic prostatitis is prepared from 9 chinese-medicinal materials including red sage root, red peony root, peach kernel, safflower, etc.
Description
Technical field
The present invention relates to acute and chronic prostatitic Chinese patent medicine of a kind of treatment and preparation method thereof.
Background technology
Prostatitis is male's commonly encountered diseases, and the overwhelming majority occurs in person between twenty and fifty, and prostatitis can be divided into acute and chronic two kinds clinically.Acute prostatitis is more rare clinically, and chronic prostatitis morbidity in the crowd that grows up is higher, accounts for Urologic Surgery Clinic patient's about 1/5, because of chronic prostatitis many with seminal vesiculitis, so be called prostatovesticulitis again.At present the clinical treatment situation is as follows: 1, the acute prostatitis patient should lie up, general processing such as polydipsia water and relieving constipation.The irritation sign of bladder severe patient can give analgesia spasmolytic medicine and hot water hip-bath with relief of symptoms.Antibacterials can be selected penicillin, streptomycin, ampicillin, cephalosporin and zinacef etc. for use.Acute prostatitis is behind general anti symptom treatment and anti-inflammatory treatment, and symptom often disappears in 1～2 week.Do not feel any better or increase the weight of on the contrary as symptom, the more swelling and fluctuation is arranged of prostate anus digital examination palpation, the visible abscess of ultrasound diagnosis forms, and extracts the pus person out through the perineum puncture, should be through the capable abscess incision and drainage of perineal position.2, chronic prostatitis is mainly taked following measure: massage of prostate, drug infusion, urethral dilatation, prostate periphery seal, antibacterials.All there is certain side effect in above-mentioned Therapeutic Method, and treatment cycle is long, curative effect instability, and general antibacterials are difficult for entering prostata tissue, and this also is one of reason for the treatment of clinically difficulty comparatively.
Summary of the invention
The purpose of this invention is to provide acute and chronic prostatitic Chinese patent medicine of a kind of treatment and preparation method thereof, be used for the acute and chronic prostatitis due to the dampness and heat stasis, without any side effects, easy to use, short treating period, stable curative effect.
Solution of the present invention is based on motherland's medical science to therapeutic prostatitis and pathogenetic understanding of complication and Therapeutic Principle, with reference to the modern pharmacological research achievement, by traditional Chinese medical science prescription theory, skims the cream off milk, and makes its performance clearing away heat-damp and promoting diuresis, the effect of blood-activating analgetic.
Chinese patent medicine of the present invention comprises the crude drug of following component: (consumption is a weight portion)
20～30 parts of 20～30 parts of Radix Paeoniae Rubra of 60～90 parts of Radix Salviae Miltiorrhizaes of Herba Patriniae
20～30 parts of 20～30 parts of Herba Lycopi of 20～30 parts of Flos Carthamis of Semen Persicae
4～6 parts of 20～30 parts of Myrrhas of Folium Pyrrosiae.
In the above-mentioned raw materials medicine, also can add 8～15 parts in 4～6 parts of Olibanums and/or Talcum.
The best component proportioning of Chinese patent medicine of the present invention is: (consumption is a weight portion)
23.4 parts in 23.4 parts of Semen Persicaes of 23.4 parts of Radix Paeoniae Rubra of 70.2 parts of Radix Salviae Miltiorrhizaes of Herba Patriniae
4.7 parts of 23.4 parts of Myrrhas of 23.4 parts of Folium Pyrrosiaes of 23.4 parts of Herba Lycopi of Flos Carthami.
In the above-mentioned raw materials medicine, also can add 11.7 parts in 4.7 parts of Olibanums and/or Talcum.
The preparation method of above-mentioned each component being made Chinese patent medicine of the present invention is:
Myrrha and/or frankincense powder are broken into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3～7 times of amounts of 95% ethanol, extract secondary, and each 1～3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density and is determined as 1.32～1.36 thick paste at 60 ℃, and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae and/or Talcum and the alcohol extraction add 8～12 times of water gagings and decoct secondary, decoct collecting decoction 1～3 hour at every turn, filter, filtrate decompression is concentrated into relative density and is determined as 1.32～1.36 thick paste at 60 ℃, adds the thick paste of Myrrha and/or Olibanum fine powder and ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.
Get the strong effects for removing toxic heat of Herba Patriniae among the we, the power of Semen Persicae, the pain relieving of Flos Carthami activating blood, resolving stasis, dispelling painful abdominal mass is strong, is monarch drug altogether; Herba Lycopi, Folium Pyrrosiae, Talcum principal drug assistance clearing away heat-damp and promoting diuresis, relieving stranguria by diuresis is a ministerial drug; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Olibanum, Myrrha blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain are adjuvant drug.All medicines gather clearing away heat-damp and promoting diuresis altogether, and the function of blood-activating analgetic is subdued the prostatic hyperplasia inflammation, and helping to change of urinating painfully separated.We's characteristic is mainly based on dispersing swelling and dissipating binds, hypertrophy is subdued; it is unobstructed to urinate; Herba Patriniae is as a kind of important heat and toxic materials clearing away medicine; be used for the treatment of various acute infectious disease; especially struvite hypertrophy to be renderd a service and distinguishedly thickened as the rope bar; enclosed mass and tenderness etc. all has better curative effect; compatibility blood circulation promoting and blood stasis dispelling again; the Radix Salviae Miltiorrhizae of reducing swelling and alleviating pain, Radix Paeoniae Rubra, Semen Persicae, Flos Carthami, Olibanum, Myrrha strengthen the merit of its anti-inflammation detumescence, again with the Herba Lycopi, Folium Pyrrosiae; Talcum collateral dredging diuresis is separated also the urinate crime of capable, happy then suffering of patient.
Advantage of the present invention is:
Raising day by day along with modernization of Chinese medicine degree, on the basis of herbal pharmacology and fitochemical studies, pharmaceutically active ingredient or effective site are proved to be definite curative effect and obtain purification in increasing, the present invention arises at the historic moment in this evolution, its scientific and technical content height is modern herbal species, and is without any side effects, easy to use, stable curative effect.
For showing medicine of the present invention to prostatitic therapeutic effect, the present invention is through the clinical observation of 102 routine systems, and prostatitis patient is the male, all meets inclusion criteria, does not have and withdraws from and reject case.At 31 years old～64 years old its age, acute and chronic prostatitis patient is respectively 41 examples, 61 examples.All case all meets the dampness and heat stasis standard.
Instructions of taking: 5 of Chinese patent medicines of the present invention a time, 3 times on the one, treatment time is January.
Therapeutic outcome sees Table 1, table 2.
Table 1 therapeutic outcome
| Case load | Recovery from illness | Produce effects | Effectively | Invalid | Total effective rate (%) |
| 102 | 37 | 40 | 15 | 10 | 90.2 |
Table 2 curative effect and sick relation of planting
| The sick kind and case load | Recovery from illness | Produce effects | Effectively | Invalid | Total effective rate (%) |
| Acute prostatitis 41 chronic prostatitiss 61 | 13 23 | 13 22 | 9 12 | 6 4 | 85.4 93.4 |
Any toxicity and side effect are not found in the clinical use of 102 routine patients, and liver, kidney merit do not have change before and after the treatment.
In sum, medicine of the present invention has clearing away heat-damp and promoting diuresis, and the effect of blood-activating analgetic has analgesic activity, the reaction that can reduce inflammation, and total effective rate is 90.2%, is worth clinical expansion to use.
Specific embodiment
Embodiment 1
Press column weight amount weighting raw materials (unit: gram)
Herba Patriniae 70.2 Radix Salviae Miltiorrhizaes 23.4 Radix Paeoniae Rubra 23.4 Semen Persicaes 23.4 Flos Carthamis 23.4
Herba Lycopi's 23.4 Folium Pyrrosiaes 23.4 Myrrhas 4.7 Olibanums 4.7.
Preparation method: above-mentioned Myrrha, frankincense powder are broken into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3～7 times of amounts of 95% ethanol, extract secondary, and each 1～3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density be 1.32～1.36 thick paste of (60 ℃ time survey), and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae and the alcohol extraction add 8～12 times of water gagings and decoct secondary, decoct collecting decoction 1～3 hour at every turn, filter, filtrate decompression is concentrated into relative density be 1.32～1.36 thick paste of (60 ℃ time survey), adds Myrrha and the fine powder of Olibanum and the thick paste of ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.
Embodiment 2
Press column weight amount weighting raw materials (unit: gram)
Herba Patriniae 70.2 Radix Salviae Miltiorrhizaes 23.4 Radix Paeoniae Rubra 23.4 Semen Persicaes 23.4 Flos Carthamis 23.4
Herba Lycopi's 23.4 Folium Pyrrosiaes 23.4 Myrrhas 4.7 Talcums 11.7.
Preparation method: above-mentioned Myrrha is ground into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3～7 times of amounts of 95% ethanol, extract secondary, and each 1～3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density be 1.32～1.36 thick paste of (60 ℃ time survey), and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae, Talcum and the alcohol extraction add 8～12 times of water gagings and decoct secondary, decoct collecting decoction 1～3 hour at every turn, filter, filtrate decompression is concentrated into relative density be 1.32～1.36 thick paste of (60 ℃ time survey), adds the thick paste of Myrrha fine powder and ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.
Embodiment 3
Press column weight amount weighting raw materials (unit: gram)
Herba Patriniae 70.2 Radix Salviae Miltiorrhizaes 23.4 Radix Paeoniae Rubra 23.4 Semen Persicaes 23.4 Flos Carthamis 23.4
Herba Lycopi's 23.4 Folium Pyrrosiaes 23.4 Myrrhas 4.7 Olibanums 4.7 Talcums 11.7.
Preparation method: above-mentioned Myrrha, frankincense powder are broken into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3～7 times of amounts of 95% ethanol, extract secondary, and each 1～3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density be 1.32～1.36 thick paste of (60 ℃ time survey), and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae, Talcum and the alcohol extraction add 8～12 times of water gagings and decoct secondary, decoct collecting decoction 1～3 hour at every turn, filter, filtrate decompression is concentrated into relative density be 1.32～1.36 thick paste of (60 ℃ time survey), adds Myrrha and the fine powder of Olibanum and the thick paste of ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.
Embodiment 4
Press column weight amount weighting raw materials (unit: gram)
Herba Patriniae 70.2 Radix Salviae Miltiorrhizaes 23.4 Radix Paeoniae Rubra 23.4 Semen Persicaes 23.4 Flos Carthamis 23.4
Herba Lycopi's 23.4 Folium Pyrrosiaes 23.4 Myrrhas 4.7.
Preparation method: above-mentioned Myrrha is ground into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3～7 times of amounts of 95% ethanol, extract secondary, and each 1～3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density be 1.32～1.36 thick paste of (60 ℃ time survey), and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae and the alcohol extraction add 8～12 times of water gagings and decoct secondary, decoct collecting decoction 1～3 hour at every turn, filter, filtrate decompression is concentrated into relative density be 1.32～1.36 thick paste of (60 ℃ time survey), adds the thick paste of Myrrha fine powder and ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.
Embodiment 5
Press column weight amount weighting raw materials (unit: gram)
Herba Patriniae 60 Radix Salviae Miltiorrhizaes 20 Radix Paeoniae Rubra 20 Semen Persicaes 20 Flos Carthamis 20
Herba Lycopi's 20 Folium Pyrrosiaes 20 Myrrhas 4 Olibanums 4 Talcums 8.
Preparation method: above-mentioned Myrrha, frankincense powder are broken into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3～7 times of amounts of 95% ethanol, extract secondary, and each 1～3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density be 1.32～1.36 thick paste of (60 ℃ time survey), and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae, Talcum and the alcohol extraction add 8～12 times of water gagings and decoct secondary, decoct collecting decoction 1～3 hour at every turn, filter, filtrate decompression is concentrated into relative density be 1.32～1.36 thick paste of (60 ℃ time survey), adds Myrrha and the fine powder of Olibanum and the thick paste of ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.
Embodiment 6
Press column weight amount weighting raw materials (unit: gram)
Herba Patriniae 90 Radix Salviae Miltiorrhizaes 30 Radix Paeoniae Rubra 30 Semen Persicaes 30 Flos Carthamis 30
Herba Lycopi's 30 Folium Pyrrosiaes 30 Myrrhas 6 Olibanums 6 Talcums 15.
Preparation method: above-mentioned Myrrha, frankincense powder are broken into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3～7 times of amounts of 95% ethanol, extract secondary, and each 1～3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density be 1.32～1.36 thick paste of (60 ℃ time survey), and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae, Talcum and the alcohol extraction add 8～12 times of water gagings and decoct secondary, decoct collecting decoction 1～3 hour at every turn, filter, filtrate decompression is concentrated into relative density be 1.32～1.36 thick paste of (60 ℃ time survey), adds Myrrha and the fine powder of Olibanum and the thick paste of ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.
Embodiment 7
Press column weight amount weighting raw materials (unit: jin)
Herba Patriniae 75 Radix Salviae Miltiorrhizaes 25 Radix Paeoniae Rubra 25 Semen Persicaes 25 Flos Carthamis 25
Herba Lycopi's 25 Folium Pyrrosiaes 25 Myrrhas 5 Talcums 10.
Preparation method: above-mentioned Myrrha is ground into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3～7 times of amounts of 95% ethanol, extract secondary, and each 1～3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density be 1.32～1.36 thick paste of (60 ℃ time survey), and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae, Talcum and the alcohol extraction add 8～12 times of water gagings and decoct secondary, decoct collecting decoction 1～3 hour at every turn, filter, filtrate decompression is concentrated into relative density be 1.32～1.36 thick paste of (60 ℃ time survey), adds the thick paste of Myrrha fine powder and ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.
Embodiment 8
Press column weight amount weighting raw materials (unit: kilogram)
Herba Patriniae 81 Radix Salviae Miltiorrhizaes 27 Radix Paeoniae Rubra 27 Semen Persicaes 27 Flos Carthamis 27
Herba Lycopi's 27 Folium Pyrrosiaes 27 Myrrhas 4.5 Talcums 12.
Preparation method: above-mentioned Myrrha is ground into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3～7 times of amounts of 95% ethanol, extract secondary, and each 1～3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density be 1.32～1.36 thick paste of (60 ℃ time survey), and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae, Talcum and the alcohol extraction add 8～12 times of water gagings and decoct secondary, decoct collecting decoction 1～3 hour at every turn, filter, filtrate decompression is concentrated into relative density be 1.32～1.36 thick paste of (60 ℃ time survey), adds the thick paste of Myrrha fine powder and ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.
Embodiment 9
Press column weight amount weighting raw materials (unit: kilogram)
Herba Patriniae 78 Radix Salviae Miltiorrhizaes 26 Radix Paeoniae Rubra 26 Semen Persicaes 26 Flos Carthamis 26
Herba Lycopi's 26 Folium Pyrrosiaes 26 Myrrhas 5.4 Olibanums 5.4.
Preparation method: above-mentioned Myrrha and frankincense powder are broken into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3～7 times of amounts of 95% ethanol, extract secondary, and each 1～3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density be 1.32～1.36 thick paste of (60 ℃ time survey), and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae and the alcohol extraction add 8～12 times of water gagings and decoct secondary, decoct collecting decoction 1～3 hour at every turn, filter, filtrate decompression is concentrated into relative density be 1.32～1.36 thick paste of (60 ℃ time survey), adds Myrrha and the fine powder of Olibanum and the thick paste of ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.
Embodiment 10
Press column weight amount weighting raw materials (unit: kilogram)
Herba Patriniae 66 Radix Salviae Miltiorrhizaes 22 Radix Paeoniae Rubra 22 Semen Persicaes 22 Flos Carthamis 22
Herba Lycopi's 22 Folium Pyrrosiaes 22 Myrrhas 4.5.
Preparation method: above-mentioned Myrrha is ground into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3～7 times of amounts of 95% ethanol, extract secondary, and each 1～3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density be 1.32～1.36 thick paste of (60 ℃ time survey), and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae and the alcohol extraction add 8～12 times of water gagings and decoct secondary, decoct collecting decoction 1～3 hour at every turn, filter, filtrate decompression is concentrated into relative density be 1.32～1.36 thick paste of (60 ℃ time survey), adds the thick paste of Myrrha fine powder and ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.
Claims (5)
1, the acute and chronic prostatitic Chinese patent medicine of a kind of treatment is characterized in that comprising following bulk drugs:
20～30 parts of 20～30 parts of Radix Paeoniae Rubra of 60～90 parts of Radix Salviae Miltiorrhizaes of Herba Patriniae
20～30 parts of 20～30 parts of Herba Lycopi of 20～30 parts of Flos Carthamis of Semen Persicae
4～6 parts of 20～30 parts of Myrrhas of Folium Pyrrosiae.
2, the acute and chronic prostatitic Chinese patent medicine of treatment as claimed in claim 1 is characterized in that comprising following bulk drugs:
23.4 parts in 23.4 parts of Semen Persicaes of 23.4 parts of Radix Paeoniae Rubra of 70.2 parts of Radix Salviae Miltiorrhizaes of Herba Patriniae
4.7 parts of 23.4 parts of Myrrhas of 23.4 parts of Folium Pyrrosiaes of 23.4 parts of Herba Lycopi of Flos Carthami.
3, the acute and chronic prostatitic Chinese patent medicine of treatment as claimed in claim 1 is characterized in that adding 8～15 parts in 4～6 parts of Olibanums and/or Talcum in described raw material.
4, the acute and chronic prostatitic Chinese patent medicine of treatment as claimed in claim 2 is characterized in that adding 11.7 parts in 4.7 parts of Olibanums and/or Talcum in described raw material.
5, the preparation method as Chinese patent medicine as described in the claim 1,2,3 or 4 is:
Myrrha and/or frankincense powder are broken into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3～7 times of amounts of 95% ethanol, extract secondary, and each 1～3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density and is determined as 1.32～1.36 thick paste at 60 ℃, and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae and/or Talcum and the alcohol extraction add 8～12 times of water gagings and decoct secondary, decoct collecting decoction 1～3 hour at every turn, filter, filtrate decompression is concentrated into relative density and is determined as 1.32～1.36 thick paste at 60 ℃, adds the thick paste of Myrrha and/or Olibanum fine powder and ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100963607A CN100394934C (en) | 2005-11-17 | 2005-11-17 | Ready prepared Chinese medicine for treating acute, chronic prostatitis and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100963607A CN100394934C (en) | 2005-11-17 | 2005-11-17 | Ready prepared Chinese medicine for treating acute, chronic prostatitis and its preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1785325A true CN1785325A (en) | 2006-06-14 |
| CN100394934C CN100394934C (en) | 2008-06-18 |
Family
ID=36782993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100963607A Active CN100394934C (en) | 2005-11-17 | 2005-11-17 | Ready prepared Chinese medicine for treating acute, chronic prostatitis and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100394934C (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101637592B (en) * | 2009-07-10 | 2011-07-13 | 李小平 | Diuresis antibiotic pill |
| CN102579754A (en) * | 2012-02-21 | 2012-07-18 | 简福川 | Chinese medicament for treating qi stagnation and blood stasis type prostatitis |
| CN102846759A (en) * | 2011-06-27 | 2013-01-02 | 西安千禾药业有限责任公司 | Pharmaceutical composition for treating acute and chronic prostatitis and preparation method thereof |
| CN103048416A (en) * | 2011-10-14 | 2013-04-17 | 西安千禾药业有限责任公司 | Detection method of Chinese medicinal composition for treating acute and chronic prostatitis |
| CN104547123A (en) * | 2013-10-16 | 2015-04-29 | 西安千禾药业有限责任公司 | Preparation method of traditional Chinese medicine composition Qianlieping for treating acute and chronic prostatitis |
| CN106511631A (en) * | 2016-10-25 | 2017-03-22 | 西安千禾药业股份有限公司 | Qianlieping preparation used for treating prostatitis and preparation method thereof |
| CN110882313A (en) * | 2019-12-09 | 2020-03-17 | 西安千禾药业股份有限公司 | Medicine for treating irregular menstruation, acute and chronic pelvic inflammatory disease and cervicitis and application thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1090778A (en) * | 1993-12-22 | 1994-08-17 | 黄海明 | " Qianzengshu " medical health bag |
| CN1054530C (en) * | 1996-04-26 | 2000-07-19 | 李建平 | Qianliehuixiao pill for treating prostatitis and prostatic hyperplasia |
| CN1478500A (en) * | 2002-08-28 | 2004-03-03 | 张安学 | Adhesive plaster for treating prostatitis |
-
2005
- 2005-11-17 CN CNB2005100963607A patent/CN100394934C/en active Active
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101637592B (en) * | 2009-07-10 | 2011-07-13 | 李小平 | Diuresis antibiotic pill |
| CN102846759A (en) * | 2011-06-27 | 2013-01-02 | 西安千禾药业有限责任公司 | Pharmaceutical composition for treating acute and chronic prostatitis and preparation method thereof |
| CN103048416A (en) * | 2011-10-14 | 2013-04-17 | 西安千禾药业有限责任公司 | Detection method of Chinese medicinal composition for treating acute and chronic prostatitis |
| CN102579754A (en) * | 2012-02-21 | 2012-07-18 | 简福川 | Chinese medicament for treating qi stagnation and blood stasis type prostatitis |
| CN104547123A (en) * | 2013-10-16 | 2015-04-29 | 西安千禾药业有限责任公司 | Preparation method of traditional Chinese medicine composition Qianlieping for treating acute and chronic prostatitis |
| CN104547123B (en) * | 2013-10-16 | 2017-06-30 | 西安千禾药业有限责任公司 | A kind of flat preparation method in Chinese medicine composition prostatitis for treating acute and chronic prostatitis |
| CN106511631A (en) * | 2016-10-25 | 2017-03-22 | 西安千禾药业股份有限公司 | Qianlieping preparation used for treating prostatitis and preparation method thereof |
| CN110882313A (en) * | 2019-12-09 | 2020-03-17 | 西安千禾药业股份有限公司 | Medicine for treating irregular menstruation, acute and chronic pelvic inflammatory disease and cervicitis and application thereof |
| CN110882313B (en) * | 2019-12-09 | 2021-12-21 | 西安千禾药业股份有限公司 | Medicine for treating irregular menstruation, acute and chronic pelvic inflammatory disease and cervicitis and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100394934C (en) | 2008-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1785325A (en) | Ready prepared Chinese medicine for treating acute, chronic prostatitis and its preparation method | |
| CN1739638A (en) | Medicine for treating dermatosis and its prepn | |
| CN102058673B (en) | Chinese medicine composition for expelling wind and removing dampness and preparation method thereof | |
| CN1742903A (en) | Medicine for treating prostatitis and hyperlasia of prostate | |
| CN100344306C (en) | Medicine composition for treating urinary system stone and inflammation | |
| CN1927322A (en) | Liposoluble traditional medicine bougie for treating acute and chronic prostatitis, and manufacturing technique thereof | |
| CN103705632B (en) | The application of BUPIXIAO PIAN in preparation treatment penile induration disease drug | |
| CN1695682A (en) | External use preparation for treating rheumatisma and bone injuries | |
| CN1876088A (en) | A medicine for treating chronic prostatitis and preparation method thereof | |
| CN1259078C (en) | Chinese medicine for treating women's chronic pelvic infection | |
| CN100335083C (en) | Pile treating Chinese medicine prepn and its production process | |
| CN1051468C (en) | Capsule for curing rheumatism | |
| CN1259943C (en) | Prostate hyperplasia pharmaceutical and method for making same | |
| CN1275628C (en) | Immediat effect medicinal paste for treating prostatitis | |
| CN1270755C (en) | Pharmaceutical composition for treating rheumatic arthritis and rheumatoid arthritis | |
| CN1686414A (en) | Wound dispelling swell dispersing tincture and its preparation method | |
| CN1062480C (en) | Oral liquor for curing urethritis | |
| CN1086297C (en) | A Chinese medicinal pill for treating gynecological diseases | |
| CN1382439A (en) | Application of sophocarpidine oxide in preparing medicine to treat ulcerative colitis | |
| CN1548065A (en) | Compound Chinese medicine for treating chronic pulvic infection and prepn process of its prepn forms | |
| CN102824573B (en) | Medicine for treating prostatic diseases | |
| CN1276761C (en) | Compound traditional Chinese and western medicine for treating rheumatism and osteoarthritis and productive method thereof | |
| CN1281239C (en) | Chinese medicine composition for treating stone | |
| CN1899390A (en) | External use analgesic hemostatic preparation and its preparing method | |
| CN1424104A (en) | Medicines for treating chronic prostatitis and preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee | ||
| CP02 | Change in the address of a patent holder |
Address after: High tech Zone Zhang Bayi Road 710065 Shaanxi city of Xi'an province No. 1 Huixin IBC-B block 11 layer Patentee after: XI'AN CHIHO PHARMACEUTICAL Co.,Ltd. Address before: 710075 Shaanxi city of Xi'an province high tech Industrial Development Zone, high tech Road No. 52 building 17 layer Patentee before: XI'AN CHIHO PHARMACEUTICAL Co.,Ltd. |
|
| C35 | Partial or whole invalidation of patent or utility model | ||
| IP01 | Partial invalidation of patent right |
Commission number: 4W101669 Conclusion of examination: The patent continued to be maintained on the basis of the technical scheme and claim 6 of talc, as required in Patent No. 200510096360.7, 3, and 4. Decision date of declaring invalidation: 20130522 Decision number of declaring invalidation: 20405 Denomination of invention: Ready prepared Chinese medicine for treating acute, chronic prostatitis and its preparation method Granted publication date: 20080618 Patentee: XI'AN CHIHO PHARMACEUTICAL Co.,Ltd. |
|
| CP01 | Change in the name or title of a patent holder | ||
| CP01 | Change in the name or title of a patent holder |
Address after: High tech Zone Zhang Bayi Road 710065 Shaanxi city of Xi'an province No. 1 Huixin IBC-B block 11 layer Patentee after: XI' AN CHIHO PHARMACEUTICAL Co.,Ltd. Address before: High tech Zone Zhang Bayi Road 710065 Shaanxi city of Xi'an province No. 1 Huixin IBC-B block 11 layer Patentee before: XI'AN CHIHO PHARMACEUTICAL Co.,Ltd. |
|
| IP01 | Partial invalidation of patent right | ||
| IP01 | Partial invalidation of patent right |
Commission number: 4W104194 Conclusion of examination: The patent is valid on the basis of the addition of talc in claim No. 200510096360.7, 3, and the technical scheme and claim 4 of talc and frankincense, 6. Decision date of declaring invalidation: 20160920 Decision number of declaring invalidation: 30074 Denomination of invention: Ready prepared Chinese medicine for treating acute, chronic prostatitis and its preparation method Granted publication date: 20080618 Patentee: XI' AN CHIHO PHARMACEUTICAL Co.,Ltd. |